Literature DB >> 35074599

Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations.

David J Jackson1, James E Gern2.   

Abstract

Rhinovirus infections can cause wheezing illnesses in all age groups. In preschool children, rhinovirus infections frequently initiate acute wheezing illnesses. Children who wheeze with rhinoviruses are at increased risk to go on to develop asthma. Once asthma is established, rhinovirus infections are potent triggers for acute airway obstruction and exacerbations in children and adults. Paradoxically, for most individuals, rhinovirus infections commonly cause cold symptoms with little or no involvement of the lower airways. This paradox has led investigators to identify specific risk factors and mechanisms for rhinovirus wheezing, and this review will outline progress in 3 main areas. First, the 3 species of rhinoviruses have different patterns of infection and virulence. Second, personal factors such as lung function and immunity influence lower respiratory outcomes of rhinovirus infection. The mucosal immune response is critical, and the quality of the interferon response and allergic inflammation interacts to determine the risk for rhinovirus wheezing. Finally, rhinovirus infections can promote pathogen-dominated airway microbiota that increase the risk for wheezing. Although specific antivirals for rhinovirus are still not available, identifying risk factors for wheezing illnesses has provided several other potential targets and strategies for reducing the risk of rhinovirus-induced wheezing and exacerbations of asthma.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Asthma; Exacerbation; Infection; Rhinovirus; Type 2 inflammation

Mesh:

Substances:

Year:  2022        PMID: 35074599     DOI: 10.1016/j.jaip.2022.01.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  1 in total

1.  Perspectives in Respiratory Infections and the Lung.

Authors:  Anne M Fitzpatrick; William W Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.